DNAPrint Genomics, Inc.
DNAG · OTC
12/31/2006 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,348 | -$8,716 | -$3,735 | -$7,790 |
| Dep. & Amort. | $1,054 | $877 | $1,052 | $1,040 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $2,349 | $585 | -$1,108 | $85 |
| Other Non-Cash | $3,678 | $3,647 | $27 | $5,135 |
| Operating Cash Flow | -$5,782 | -$3,606 | -$3,764 | -$1,530 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$391 | -$124 | -$57 | -$14 |
| Net Acquisitions | $555 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$2,275 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $202 | -$194 | $0 |
| Investing Cash Flow | $163 | -$2,196 | -$251 | -$14 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,371 | $2,302 | -$149 | $653 |
| Stock Issued | $3,034 | $4,463 | $4,621 | $906 |
| Stock Repurch. | $0 | -$135 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $255 | $238 |
| Financing Cash Flow | $4,405 | $6,630 | $4,728 | $1,798 |
| Forex Effect | $1 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$1,212 | $828 | $713 | $254 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,807 | $979 | $266 | $12 |
| End Cash | $595 | $1,807 | $979 | $266 |
| Free Cash Flow | -$6,173 | -$3,729 | -$3,821 | -$1,544 |